Related Experiment Video
Updated: Aug 11, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Neuroprotection in Parkinson's disease; a commentary
Emilia Mabel Gatto1, Natalia Riobó, María Cecilia Carreras
1Programa de Parkinson y Movimientos Anormales, Hospital de Clinicas, Universidad de Buenos Aires, Buenos Aires, Argentina. emiliagatto@fibertel.com.ar
Neurotoxicity Research
|June 28, 2003
Summary
Parkinson's disease (PD) research explores neuroprotective strategies. Emerging treatments targeting oxidative stress and neuroinflammation show promise for rescuing dopaminergic neurons.
Area of Science:
- Neuroscience
- Neurology
- Pharmacology
Background:
- Parkinson's disease (PD) is a global neurodegenerative disorder with complex etiology, including genetic and environmental factors.
- Current treatments offer limited neuroprotection, highlighting the need for novel therapeutic approaches.
- Pathophysiological mechanisms in PD involve oxidative stress, excitotoxicity, mitochondrial dysfunction, and nitric oxide (NO) overproduction.
Purpose of the Study:
- To review current understanding of Parkinson's disease pathophysiology.
- To explore emerging neuroprotective strategies and potential therapeutic agents.
- To identify novel treatments aimed at rescuing dopaminergic neurons.
Main Methods:
- Review of existing literature on Parkinson's disease mechanisms and treatments.
- Analysis of various neuroprotective agents and their mechanisms of action.
- Evaluation of experimental models of Parkinson's disease.
Main Results:
- Classical PD drugs provide only modest neuroprotective effects.
- Several novel therapeutic strategies demonstrate significant neuroprotective properties in experimental models.
- Agents targeting glutamate receptors, NO pathways, and apoptosis show promise.
Conclusions:
- New therapeutic strategies offer significant potential for Parkinson's disease treatment.
- Targeting specific pathophysiological pathways like oxidative stress and apoptosis is crucial.
- Further research into neuroprotectants and dopaminergic neuron rescue agents is warranted.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...